Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Consensus Price Target from Analysts
Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […]
